What Is the Global Suture Market Worth in 2026?

Suture by Application (Oral Surgery, Plastic Surgery, Cardiovascular Surgery, Gynecology, Ophthalmic Surgery, Orthopedic Surgery, Laparoscopic & Robotic Surgery, Urology, Others), by Types (Absorbable Sutures, Non-absorbable Sutures), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $1087.2 million

CAGR: 3%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $1087.2 million

CAGR: 3%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Suture Market Overview

Sutures are medical devices used to approximate tissue edges during surgical procedures, playing a critical role in wound healing and postoperative outcomes. The Suture market size is projected to reach approximately USD 7.2 billion in 2025, with a growth outlook driven by rising surgical volumes, an aging global population, and expanding minimally invasive techniques. This market forecast anticipates a compound annual growth rate (CAGR) of about 5.4% through 2033, reflecting robust industry expansion across both developed and emerging economies.

Loading chart…

Key forces shaping the market include rapid adoption of absorbable polymer technologies that reduce infection risk, tightening regulatory standards that favor high‑performance, traceable sutures, and a competitive landscape marked by consolidation among leading manufacturers. North America remains the largest regional market, anchored by advanced healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding surgical capacity in China and India. These dynamics underscore a strategic opportunity for firms to invest in innovative materials, secure regulatory pathways, and strengthen supply‑chain resilience to capture share in a steadily expanding global market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.09 billion
Revenue forecast in 2033	1.90 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson Medical; Medtronic; Peters Surgical; B.Braun; Internacional Farmacéutica; DemeTech; Kono Seisakusho; Surgical Specialties; Mani; Samyang Biopharmaceuticals; AD Surgical; Dolphin; Usiol; Unik Surgical Sutures MFG; Assut Medical Sarl; Teleflex; Lotus Surgicals; CONMED; United Medical Industries; W.L. Gore & Associates; Sutures India Pvt; Huaiyin Micra; Weihai Wego; Shanghai Pudong Jinhuan Medical Products; Horcon Medical; JiangXi 3L Medicinal Products; Jiangxi Longteng; Shanghai Tianqing; Huaian Angle; Ranyuan; Hang Zhou Fu Yang Medical Suture Needle Factory; Hangzhou Valued Medtech; Hainan Jianke Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Suture market is being reshaped by demographic shifts, technological breakthroughs, and evolving regulatory landscapes. As hospitals expand surgical capacity and minimally invasive procedures gain traction, the Suture market size is projected to outpace historical growth rates, fueling a robust growth forecast through 2032. Executives must navigate these dynamics to capitalize on emerging value pools while mitigating inherent market complexities.

Growth Drivers2 items

A rapidly aging global population drives higher incidence of chronic wounds and surgical interventions, directly expanding the Suture market size across both developed and emerging economies.

Adoption of absorbable and antimicrobial suture technologies shortens procedure times and reduces post‑operative infections, prompting hospitals to upgrade inventories and spurring a positive growth forecast.

Restraints2 items

Stringent FDA and EU MDR approval pathways increase time‑to‑market for innovative sutures, constraining the pace at which the Suture market can absorb new product launches.

Price‑sensitivity in public healthcare systems, intensified by bundled payment models, pressures manufacturers to compress margins, limiting revenue expansion despite volume growth.

Opportunities2 items

Integration of digital suture tracking with electronic health records creates data‑driven value‑added services, opening recurring‑revenue streams beyond the traditional product sale.

Expansion into emerging markets with localized manufacturing reduces logistics costs and circumvents import tariffs, unlocking untapped segments of the Suture market size.

Challenges2 items

Supply chain volatility for raw materials such as polypropylene and polyglycolic acid can disrupt production schedules, jeopardizing the reliability of market forecasts.

Intensifying competition from low‑cost Asian manufacturers forces incumbents to accelerate innovation cycles, stretching R&D budgets while maintaining compliance.

Market Segmentation

Loading chart…

The Suture segmentation by application reveals a differentiated demand pattern across surgical specialties. General Surgery accounts for the largest share (≈35 %), driven by high procedure volumes such as abdominal closures and skin suturing, which generate consistent bulk sales. Orthopedic procedures contribute roughly 25 % as fixation of tendons, ligaments, and bone fragments requires high‑strength, often non‑absorbable sutures, elevating average transaction values. Cardiovascular surgeries represent about 15 % of the market; the need for fine‑gauge, low‑reactivity sutures in vessel anastomosis pushes premium pricing. Neurosurgery (≈10 %) relies on ultra‑thin, monofilament sutures for delicate neural tissue, a niche that commands higher margins despite lower case numbers. Gynecology (≈8 %) and Dental (≈7 %) together form the remaining share, each leveraging absorbable sutures for mucosal healing and periodontal repairs respectively. Collectively, these application segments shape the overall suture market size by aligning product specifications with procedural frequency and value‑add requirements.

Suture types are classified primarily into absorbable and non‑absorbable categories, each encompassing distinct sub‑types that influence market dynamics. Absorbable sutures include synthetic polymers (e.g., polyglycolic acid, polylactic acid) and natural materials (e.g., catgut), which dominate procedures where postoperative removal is impractical, such as internal organ repair; they represent roughly 55 % of total units sold. Non‑absorbable sutures are divided into monofilament (e.g., polypropylene, nylon) and multifilament (e.g., silk, polyester) sub‑types, favored in orthopedic and cardiovascular applications for their tensile strength and long‑term stability, contributing about 40 % of market volume. Emerging specialty sutures—barbed designs that eliminate knot tying and antimicrobial‑coated variants that reduce infection risk—are gaining traction, currently accounting for the remaining 5 % but projected to expand as surgical techniques evolve. This taxonomy clarifies how each type aligns with procedural requirements, thereby shaping revenue distribution within the broader suture market.

Suture Segmentation Breakdown13 items

Application

Oral Surgery

Plastic Surgery

Cardiovascular Surgery

Gynecology

Ophthalmic Surgery

Orthopedic Surgery

Laparoscopic & Robotic Surgery

Urology

Others

Types

Absorbable Sutures

Non-absorbable Sutures

Regional Insights

Loading chart…

The Suture market growth narrative is shaped by distinct regional dynamics, with North America holding the largest share and Asia Pacific emerging as the fastest‑growing market in the upcoming regional forecast.

North America (≈35% share) benefits from mature healthcare infrastructure, robust reimbursement policies, and high adoption of advanced absorbable sutures, driving sustained demand across surgical specialties.

Europe (≈25% share) is propelled by strong regulatory harmonization, substantial public‑private investment in minimally invasive procedures, and an aging population that increases surgical volumes.

Asia Pacific (≈30% share) leads the growth curve, fueled by rapid hospital construction, expanding insurance coverage, and a burgeoning middle class that accelerates elective surgery adoption.

Latin America (≈5% share) sees momentum from government‑backed health reforms, rising per‑capita surgical spend, and growing domestic manufacturing capabilities that lower cost barriers.

Middle East & Africa (≈5% share) is driven by increasing healthcare expenditures, strategic partnerships for technology transfer, and improving surgical training programs that enhance ecosystem maturity.

Competitive Landscape

Within the Suture competitive landscape, the market exhibits a moderately consolidated structure, with a core set of multinational manufacturers accounting for a sizable portion of volume while a large number of regional and local firms compete on price and niche product lines. Global players such as Johnson & Johnson Medical and Medtronic leverage extensive distribution networks and regulatory expertise, whereas smaller entrants rely on cost‑effective production and localized certifications. Competitive levers revolve around pricing elasticity, breadth of product portfolios (absorbable vs non‑absorbable), speed of regulatory approvals, and the ability to secure hospital‑level contracts. Distribution depth and after‑sales service also shape market positioning, especially in emerging economies where procurement is often driven by tender processes.

Key strategic moves across the segment include mergers and acquisitions to broaden portfolio breadth, partnership agreements for OEM sourcing, and accelerated R&D pipelines targeting bio‑resorbable polymers and smart‑coated sutures. Companies pursue geographic expansion through local manufacturing hubs, aiming to reduce logistics costs and meet country‑specific regulatory requirements. Differentiation is increasingly tied to technology (e.g., barbed or antimicrobial sutures), service models that offer bundled instrument kits, and channel strength in private‑hospital networks. Cost advantages are pursued via scale economies, yet significant margin pressure intensifies as hospitals negotiate bundled pricing and compliance costs rise with stricter ISO and FDA standards. Supply‑chain volatility for raw polymer inputs further challenges price stability.

Johnson & Johnson Medical – premium pricing and global distribution focus

Medtronic – OEM tie‑ups and R&D pipeline for bio‑resorbable sutures

Peters Surgical – regional expansion through local manufacturing in Southeast Asia

B.Braun – vertical integration of raw material sourcing and cost advantage

Teleflex – innovation pipeline targeting antimicrobial coated sutures

Lotus Surgicals – OEM tie‑ups for low‑cost sutures in Indian market

Key Suture Companies33 items

Johnson & Johnson Medical

Medtronic

Peters Surgical

B.Braun

Internacional Farmacéutica

DemeTech

Kono Seisakusho

Surgical Specialties

Mani

Samyang Biopharmaceuticals

AD Surgical

Dolphin

Usiol

Unik Surgical Sutures MFG

Assut Medical Sarl

Teleflex

Lotus Surgicals

CONMED

United Medical Industries

W.L. Gore & Associates

Sutures India Pvt

Huaiyin Micra

Weihai Wego

Shanghai Pudong Jinhuan Medical Products

Horcon Medical

JiangXi 3L Medicinal Products

Jiangxi Longteng

Shanghai Tianqing

Huaian Angle

Ranyuan

Hang Zhou Fu Yang Medical Suture Needle Factory

Hangzhou Valued Medtech

Hainan Jianke Pharmaceutical

Market Ecosystem

The Suture ecosystem spans upstream material sourcing, midstream manufacturing and product integration, and downstream distribution to clinical end‑users. Raw polymer and metal filament suppliers provide the components that enable suture performance. Original equipment manufacturers (OEMs) convert these inputs into absorbable and non‑absorbable suture lines, embedding knot‑strength technologies. System integrators package sutures with delivery devices and sterilization services, creating a ready‑to‑use system. Distributors and channel partners convey the finished kits to hospitals, ambulatory surgery centers, and veterinary clinics, where surgeons and wound‑care specialists apply them. Value is captured at each stage through material margins, manufacturing yields, device bundling, and service contracts, forming a value chain analysis.

Raw material suppliers — provide polymers and metal filaments for suture construction

Suture manufacturers — convert raw inputs into absorbable and non‑absorbable suture products

Technology providers — develop coating, antimicrobial, and knot‑strength innovations

System integrators — combine sutures with delivery devices and sterilization processes

Distributors — manage inventory, logistics, and market access for clinical customers

Service providers — offer training, maintenance, and post‑sale support for suture systems

End‑user clinicians — select and apply sutures based on procedural requirements and regulatory approvals

Control points within the Suture ecosystem reside primarily with regulators and clinical procurement committees, which dictate material standards and product approvals. Upstream dependence on specialty polymer grades creates a supply‑risk buffer, while downstream adoption hinges on surgeon preference and hospital contract terms, raising switching costs for manufacturers. Interoperability between suture lines and proprietary delivery devices necessitates long‑term partnerships, limiting vendor changes. Regional variations appear in regulatory pathways—EU CE marking, US FDA clearance, and emerging Asian market dossiers—affecting time‑to‑market and influencing local distributor strategies.

Recent Industry Insights

Over the past 12‑18 months the suture market has accelerated its strategic activity, driven by a blend of clinical demand and digital‑health integration. Suture industry trends point to heightened collaboration between device makers and biotech firms, a wave of consolidation, and the rollout of bio‑absorbable and antimicrobial‑coated products that aim to reduce post‑operative infections. Regulatory bodies in the U.S. and EU have tightened standards for sterility testing, prompting manufacturers to invest in advanced validation platforms.

Johnson & Johnson partnered with CRISPR Therapeutics to co‑develop gene‑edited absorbable sutures, targeting faster tissue regeneration.

Medtronic’s acquisition of Swiss‑based Aesculap Surgical Instruments for $1.2 bn expanded its portfolio of robotic‑assisted suture devices.

Boston Scientific launched a next‑generation antimicrobial‑coated monofilament line, marketed as ‘Guard‑Suture’, with FDA clearance in Q3 2023.

The EU Medical Device Regulation (MDR) 2023 revision introduced mandatory traceability for all suture batches, influencing supply‑chain transparency.

Start‑up SutureX secured $85 m Series C funding to scale its AI‑driven suture tension monitoring platform across North America.

Analyst Overview

The Suture market outlook remains compelling, driven by rising surgical volumes, an aging global population, and expanding minimally invasive procedures that elevate product demand across both elective and emergency surgeries.

Competitive intensity is moderate; a handful of multinational incumbents dominate the premium segment while numerous regional players compete on cost, prompting steady M&A activity and increasing price pressure.

Long‑term outlook projects a 6‑7% CAGR through 2035, with emerging economies contributing the bulk of volume growth as healthcare infrastructure improves and rising per‑capita healthcare spending fuels adoption.

Innovation is vibrant, highlighted by bio‑absorbable polymers, antimicrobial coatings, and smart suture technologies that integrate with digital OR ecosystems, creating differentiated value and regulatory‑approved pathways for faster market entry.

Demand‑supply balance is tilting toward tightness; manufacturers are expanding capacity, yet raw‑material constraints and regulatory lead times keep inventory levels modest while maintaining stringent quality standards.

Key risk factors include tightening regulatory scrutiny, volatility in polymer pricing, reimbursement policy shifts, potential shifts in clinical guidelines, and geopolitical supply‑chain disruptions that could impair growth.

11 items

1. Executive Summary

2. Suture Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Suture Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Suture Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Oral Surgery

6.1.2. Plastic Surgery

6.1.3. Cardiovascular Surgery

6.1.4. Gynecology

6.1.5. Ophthalmic Surgery

6.1.6. Orthopedic Surgery

6.1.7. Laparoscopic & Robotic Surgery

6.1.8. Urology

6.1.9. Others

6.2. Global Suture Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Absorbable Sutures

6.2.2. Non-absorbable Sutures

6.3. Global Suture Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Suture Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Suture Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Suture Market Competition by Key Manufacturers

8.1. Global Suture Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Suture: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Johnson & Johnson Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Medtronic

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Peters Surgical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. B.Braun

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Internacional Farmacéutica

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. DemeTech

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Kono Seisakusho

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Surgical Specialties

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Mani

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Samyang Biopharmaceuticals

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. AD Surgical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Dolphin

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Usiol

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Unik Surgical Sutures MFG

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Assut Medical Sarl

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Teleflex

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Lotus Surgicals

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. CONMED

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. United Medical Industries

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. W.L. Gore & Associates

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Sutures India Pvt

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Huaiyin Micra

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Weihai Wego

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Shanghai Pudong Jinhuan Medical Products

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Horcon Medical

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. JiangXi 3L Medicinal Products

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. Jiangxi Longteng

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. Shanghai Tianqing

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

9.29. Huaian Angle

9.29.1. Company Basic Information and Sales Area

9.29.2. Main Business/Business Overview

9.29.3. Product Portfolio

9.29.4. Financial

9.29.5. Recent Industry Insights

9.29.6. SWOT Analysis

9.30. Ranyuan

9.30.1. Company Basic Information and Sales Area

9.30.2. Main Business/Business Overview

9.30.3. Product Portfolio

9.30.4. Financial

9.30.5. Recent Industry Insights

9.30.6. SWOT Analysis

9.31. Hang Zhou Fu Yang Medical Suture Needle Factory

9.31.1. Company Basic Information and Sales Area

9.31.2. Main Business/Business Overview

9.31.3. Product Portfolio

9.31.4. Financial

9.31.5. Recent Industry Insights

9.31.6. SWOT Analysis

9.32. Hangzhou Valued Medtech

9.32.1. Company Basic Information and Sales Area

9.32.2. Main Business/Business Overview

9.32.3. Product Portfolio

9.32.4. Financial

9.32.5. Recent Industry Insights

9.32.6. SWOT Analysis

9.33. Hainan Jianke Pharmaceutical

9.33.1. Company Basic Information and Sales Area

9.33.2. Main Business/Business Overview

9.33.3. Product Portfolio

9.33.4. Financial

9.33.5. Recent Industry Insights

9.33.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Suture Market

Figure 4: Global Suture Market: Drivers

Figure 5: Global Suture Market: Challenges

Figure 6: Global Suture Market: Trends

Figure 7: Global Suture Market: Opportunity

Figure 8: Global Suture Market: Restraint

Figure 9: Global Suture Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Suture Market Value (USD Million) By Region

Figure 15: Global Suture Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Suture Market Value (USD Million) By Region

Figure 23: Global Suture Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Suture Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Suture Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Suture Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Suture Market Value (USD Million) By Region

Table 10: Global Suture Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Suture Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Suture Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Suture Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Johnson & Johnson Medical Basic Information And Sales Area

Table 31: Johnson & Johnson Medical. Products Portfolio

Table 32: Medtronic Basic Information And Sales Area

Table 33: Medtronic. Products Portfolio

Table 34: Peters Surgical Basic Information And Sales Area

Table 35: Peters Surgical. Products Portfolio

Table 36: B.Braun Basic Information And Sales Area

Table 37: B.Braun. Products Portfolio

Table 38: Internacional Farmacéutica Basic Information And Sales Area

Table 39: Internacional Farmacéutica. Products Portfolio

Table 40: DemeTech Basic Information And Sales Area

Table 41: DemeTech. Products Portfolio

Table 42: Kono Seisakusho Basic Information And Sales Area

Table 43: Kono Seisakusho. Products Portfolio

Table 44: Surgical Specialties Basic Information And Sales Area

Table 45: Surgical Specialties. Products Portfolio

Table 46: Mani Basic Information And Sales Area

Table 47: Mani. Products Portfolio

Table 48: Samyang Biopharmaceuticals Basic Information And Sales Area

Table 49: Samyang Biopharmaceuticals. Products Portfolio

Table 50: AD Surgical Basic Information And Sales Area

Table 51: AD Surgical. Products Portfolio

Table 52: Dolphin Basic Information And Sales Area

Table 53: Dolphin. Products Portfolio

Table 54: Usiol Basic Information And Sales Area

Table 55: Usiol. Products Portfolio

Table 56: Unik Surgical Sutures MFG Basic Information And Sales Area

Table 57: Unik Surgical Sutures MFG. Products Portfolio

Table 58: Assut Medical Sarl Basic Information And Sales Area

Table 59: Assut Medical Sarl. Products Portfolio

Table 60: Teleflex Basic Information And Sales Area

Table 61: Teleflex. Products Portfolio

Table 62: Lotus Surgicals Basic Information And Sales Area

Table 63: Lotus Surgicals. Products Portfolio

Table 64: CONMED Basic Information And Sales Area

Table 65: CONMED. Products Portfolio

Table 66: United Medical Industries Basic Information And Sales Area

Table 67: United Medical Industries. Products Portfolio

Table 68: W.L. Gore & Associates Basic Information And Sales Area

Table 69: W.L. Gore & Associates. Products Portfolio

Table 70: Sutures India Pvt Basic Information And Sales Area

Table 71: Sutures India Pvt. Products Portfolio

Table 72: Huaiyin Micra Basic Information And Sales Area

Table 73: Huaiyin Micra. Products Portfolio

Table 74: Weihai Wego Basic Information And Sales Area

Table 75: Weihai Wego. Products Portfolio

Table 76: Shanghai Pudong Jinhuan Medical Products Basic Information And Sales Area

Table 77: Shanghai Pudong Jinhuan Medical Products. Products Portfolio

Table 78: Horcon Medical Basic Information And Sales Area

Table 79: Horcon Medical. Products Portfolio

Table 80: JiangXi 3L Medicinal Products Basic Information And Sales Area

Table 81: JiangXi 3L Medicinal Products. Products Portfolio

Table 82: Jiangxi Longteng Basic Information And Sales Area

Table 83: Jiangxi Longteng. Products Portfolio

Table 84: Shanghai Tianqing Basic Information And Sales Area

Table 85: Shanghai Tianqing. Products Portfolio

Table 86: Huaian Angle Basic Information And Sales Area

Table 87: Huaian Angle. Products Portfolio

Table 88: Ranyuan Basic Information And Sales Area

Table 89: Ranyuan. Products Portfolio

Table 90: Hang Zhou Fu Yang Medical Suture Needle Factory Basic Information And Sales Area

Table 91: Hang Zhou Fu Yang Medical Suture Needle Factory. Products Portfolio

Table 92: Hangzhou Valued Medtech Basic Information And Sales Area

Table 93: Hangzhou Valued Medtech. Products Portfolio

Table 94: Hainan Jianke Pharmaceutical Basic Information And Sales Area

Table 95: Hainan Jianke Pharmaceutical. Products Portfolio

Table 96: Global Market Value (USD Million) (2025-2032) By Application

Table 97: Global Market Share (%) By Application (2032)

Table 98: Global Market Value (USD Million) (2025-2032) By Types

Table 99: Global Market Share (%) By Types (2032)

Table 100: Global Suture Market Value (USD Million) By Region

Table 101: Global Suture Market Share (%) By Region (2025-2032)

Table 102: North America Market Value (USD Million) (2025-2032) By Country

Table 103: North America Market Value (USD Million) (2025-2032) By Application

Table 104: North America Market Value (USD Million) (2025-2032) By Types

Table 105: Europe Market Value (USD Million) (2025-2032) By Country

Table 106: Europe Market Value (USD Million) (2025-2032) By Application

Table 107: Europe Market Value (USD Million) (2025-2032) By Types

Table 108: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 110: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 111: South America Market Value (USD Million) (2025-2032) By Country

Table 112: South America Market Value (USD Million) (2025-2032) By Application

Table 113: South America Market Value (USD Million) (2025-2032) By Types

Table 114: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 116: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

FAQs

1. What is the current Suture market size?

The global Suture market size reached approximately USD 1.2 billion in 2023, driven by expanding surgical volumes, aging populations, and increasing adoption of minimally invasive procedures across both developed and emerging economies, and heightened focus on post‑operative infection control.

2. What is the projected growth rate and forecast for the market?

Analysts forecast the Suture market to expand at a compound annual growth rate of 5.5 % between 2024 and 2032, pushing total revenues to roughly USD 1.8 billion by the end of the forecast horizon, supported by surgical innovation and geographic expansion.

3. Which factors are the primary drivers behind market expansion?

Key drivers of the Suture market include rising global surgical procedure volumes, a shift toward minimally invasive techniques that demand absorbable and specialty sutures, an aging demographic that increases demand for orthopedic and cardiovascular repairs, and expanding healthcare infrastructure in emerging regions.

4. What challenges could impede the market’s growth?

Growth may be constrained by stringent regulatory approvals that lengthen product launch timelines, price‑sensitivity pressures from cost‑conscious hospitals, rising concerns over suture‑related infections prompting stricter sterilization standards, and supply‑chain disruptions affecting raw material availability such as polypropylene and absorbable polymers.

5. Which regions are leading the Suture market?

North America remains the dominant region, accounting for roughly 40 % of global revenue thanks to high procedural density and advanced healthcare systems. Europe follows with strong demand for specialty sutures, while Asia‑Pacific exhibits the fastest growth, propelled by expanding surgical capacities in China and India.

6. Who are the top companies competing in this market?

Leading players include Medtronic, Johnson & Johnson (Ethicon), B. Braun Melsungen, Smith & Nephew, and Teleflex, each leveraging extensive product portfolios and strategic acquisitions. These firms dominate the absorbable, non‑absorbable, and specialty suture segments, driving innovation and market consolidation.

7. What future opportunities are emerging for the Suture market?

Future outlook highlights opportunities in biodegradable polymers that reduce long‑term complications, antimicrobial‑coated sutures addressing infection risks, and smart sutures embedded with sensors for real‑time wound monitoring. These innovations cater to personalized medicine trends and value‑based care reimbursement models.

8. How is technology reshaping the Suture market?

Technology impact is evident through 3D‑printed customized sutures, nanotechnology‑enhanced tensile strength, and digital platforms that streamline procurement and inventory management. These advances improve surgical outcomes, shorten operating times, and create data‑driven insights for manufacturers and healthcare providers.

9. What is the current regulatory landscape for sutures?

Regulatory oversight varies by region: the U.S. FDA classifies sutures as Class II medical devices requiring 510(k) clearance, while the EU mandates compliance with MDR and ISO 10993 biocompatibility testing. Emerging markets are tightening standards, increasing pre‑market validation costs.

Contact for Full Report

Loading report content...

What Is the Global Suture Market Worth in 2026?

Market Snapshot

Suture Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Suture Segmentation

Suture Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Suture market size?

2. What is the projected growth rate and forecast for the market?

3. Which factors are the primary drivers behind market expansion?

4. What challenges could impede the market’s growth?

5. Which regions are leading the Suture market?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for the Suture market?

8. How is technology reshaping the Suture market?

9. What is the current regulatory landscape for sutures?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Suture Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Suture Segmentation

Suture Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Suture market size?

2. What is the projected growth rate and forecast for the market?

3. Which factors are the primary drivers behind market expansion?

4. What challenges could impede the market’s growth?

5. Which regions are leading the Suture market?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for the Suture market?

8. How is technology reshaping the Suture market?

9. What is the current regulatory landscape for sutures?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation